<table id="table12" width="80%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 12:  Summary of AED Interactions with TOPAMAX<sup>Â®</sup>
</caption>
<col align="left" valign="top" width="31%"></col>
<col align="left" valign="top" width="38%"></col>
<col align="left" valign="top" width="31%"></col>
<thead>
<tr>
<th>AED<br/>Co-administered</th>
<th>AED<br/>Concentration</th>
<th>Topiramate<br/>Concentration</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3">NC = Less than 10% change in plasma concentration.</td>
</tr>
<tr>
<td align="left" colspan="3">AED = Antiepileptic drug.</td>
</tr>
<tr>
<td align="left" colspan="3">NE = Not Evaluated.</td>
</tr>
<tr>
<td align="left" colspan="3">TPM = Topiramate</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>Phenytoin</td>
<td>NC or 25% increase<footnote id="t12fn1">= Plasma concentration increased 25% in some patients, generally those on a twice a day dosing regimen of phenytoin.</footnote>
</td>
<td>48% decrease</td>
</tr>
<tr>
<td>Carbamazepine (CBZ)</td>
<td>NC</td>
<td>40% decrease</td>
</tr>
<tr>
<td>CBZ epoxide<footnote id="t12fn2">= Is not administered but is an active metabolite of carbamazepine.</footnote>
</td>
<td>NC</td>
<td>NE</td>
</tr>
<tr>
<td>Valproic acid</td>
<td>11% decrease</td>
<td>14% decrease</td>
</tr>
<tr>
<td>Phenobarbital</td>
<td>NC</td>
<td>NE</td>
</tr>
<tr>
<td>Primidone</td>
<td>NC</td>
<td>NE</td>
</tr>
<tr>
<td>Lamotrigine</td>
<td>NC at TPM doses up to 400 mg/day</td>
<td>13% decrease</td>
</tr>
</tbody>
</table>